Patent ID: 7943584
Filing Date: 2011-05-17
Classification: A61K,A61P

Abstract:
1. A pharmaceutical composition comprising a combination of an α-amylase inhibitor and at least one type of drug, wherein the α-amylase inhibitor is (2R,3R,4R)-4-hydroxy-2-(hydroxymethyl)pyrrolidin-3-yl 4-O-(6-deoxy-α-D-glucopyranosyl)-α-D-glucopyranoside, (2R,3R,4R)-4-hydroxy-2-(hydroxymethyl)pyrrolidin-3-yl 4-O-(6-deoxy-β-D-glucopyranosyl)-β-D-glucopyranoside, (2R,3R,4R)-4-hydroxy-2-(hydroxymethyl)pyrrolidin-3-yl 4-O-β-D-glucopyranosyl-α-D-glucopyranoside, (2R,3R,4R)-4-hydroxy-2-(hydroxymethyl)pyrrolidin-3-yl 4-O-(6-fluoro-6-deoxy-β-D-glucopyranosyl)-D-glucopyranoside or a pharmacologically acceptable salt or ester thereof, and wherein the at least one type of drug is selected from an insulin sensitizer, insulin secretagogue, biguanide drug, and an insulin preparation.